Post-Translational Events Underlying the KSHV vGPCR Pathogenesis
Post-Translational Events Underlying the KSHV vGPCR Pathogenesis
批准号:
8246529
负责人:
Pinghui Feng
金额:
$32.98万
依托单位国家:
美国
项目类别:
财政年份:
2009
资助国家:
美国
项目状态:
已结题
起止时间:
2009-06-10 至 2014-04-30
关键词:
ApoptosisBiochemicalBiologicalBiological AssayCell DeathCellsComplexDisease ProgressionDominant-Negative MutationEndoplasmic Reticulum Degradation PathwayEukaryotic CellEventG-Protein-Coupled ReceptorsGeneticHerpesviridaeHerpesviridae InfectionsHumanHuman Herpesvirus 8Immunologic Deficiency SyndromesInfectionInflammationKaposi SarcomaLesionLinkLymphomaLyticLytic PhaseMalignant NeoplasmsMammalian CellMediatingMembrane ProteinsMissionMolecularMulticentric Angiofollicular Lymphoid HyperplasiaPapillomaPathogenesisPathway interactionsPatientsPost-Translational RegulationProteinsProteolysisRegulationRetinalRhodopsinRoleSignal TransductionSystemTumorigenicityUbiquitinationViralViral ProteinsVirusabstractingeffusiongammaherpesvirusgrowth promoting activitylytic replicationmouse modelmulticatalytic endopeptidase complexoverexpressionp97 ATPasepost-doctoral trainingprotein degradationprotein misfoldingresearch studytumortumorigenesistumorigenicubiquitin-protein ligasevirus host interaction
中文摘要
摘要/概要
标题:vGPCR发病机制的翻译后事件
人γ疱疹病毒,如卡波西肉瘤(KS)相关
疱疹病毒(KSHV)通常与免疫缺陷病毒-1感染有关,
诱发患者肿瘤。除了潜伏蛋白外,KSHV裂解蛋白也已被发现。
证明具有致瘤或促生长活性,表明裂解
复制可能有助于KS和其他KSHV相关疾病的进展,
恶性肿瘤。一个有趣的例子是KSHV编码的G蛋白偶联受体
(vGPCR)。尽管vGPCR下游的致瘤性和信号传导事件是不可避免的,
更好地定义,尚不清楚vGPCR是如何调节的。事实上,连续表达
组成型活性GPCR(例如,vGPCR或视网膜视紫红质)诱导的细胞死亡。
哺乳动物细胞,提高了KSHV已经进化出控制机制的可能性。
vGPCR表达和活性。
我们的初步研究发现,K7膜蛋白与
vGPCR并诱导其蛋白酶体降解。此外,K7在细胞中保留vGPCR。
ER和增加vGPCR泛素化。我们假设K7诱导ER-
vGPCR的相关降解,并作为vGPCR的负调节因子发挥作用
肿瘤发生我们的研究旨在阐明K7在路由中的分子作用
vGPCR对ER相关降解的影响。我们将使用遗传学和生物化学
鉴定细胞因子并表征其在K7诱导的vGPCR中的作用的试验
降解这些实验不仅将阐明细胞内调节
vGPCR,但也将揭示细胞分子,可以潜在地针对抗-
病毒疗法
英文摘要
Abstract/Summary
Title: Post-translational events underlying the pathogenesis of vGPCR
Human gamma herpesviruses such as Kaposi's sarcoma (KS)-associated
herpesvirus (KSHV) are often associated with infection of immunodeficiency virus-1 and
induce tumor in patients. In addition to latent proteins, KSHV lytic proteins have been
demonstrated to possess tumorigenic or growth-promoting activities, indicating that lytic
replication may contribute to the disease progression of KS and other KSHV-associated
malignancies. One intriguing example is the KSHV-encoded G protein-coupled receptor
(vGPCR). Although tumorigenicity and signaling events downstream of vGPCR are
better defined, it is not clear how vGPCR is regulated. In fact, continuous expression of
constitutively active GPCRs (e.g., vGPCR or retinal rhodopsin) induced cell death in
mammalian cells, raising the possibility that KSHV has evolved mechanisms to control
vGPCR expression and activity.
Our preliminary study discovered that the K7 membrane protein interacts with
vGPCR and induces its proteasome degradation. Furthermore, K7 retains vGPCR in the
ER and increases vGPCR ubiquitination. We hypothesize that K7 induces the ER-
associated degradation of vGPCR and functions as a negative regulator for vGPCR
tumorigenesis. Our study proposes to elucidate the molecular action of K7 in routing
vGPCR to the ER-associated degradation. We will employ both genetic and biochemical
assays to identify cellular factors and characterize their roles in K7-induced vGPCR
degradation. These experiments not only will elucidate the intracellular regulation of
vGPCR, but also will reveal cellular molecules that can be potentially targeted for anti-
viral therapy.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Targeting IKKepsilon-mediated nucleotide synthesis in KSHV-associated lymphoma
-
批准号:10762816
-
项目类别:
-
资助金额:$37.86万
-
财政年份:2023
-
负责人:Pinghui Feng
-
依托单位:
Explore roles of HSV-1 in Alzheimer's disease using mouse models
-
批准号:10629403
-
项目类别:
-
资助金额:$79.9万
-
财政年份:2021
-
负责人:Pinghui Feng
-
依托单位:
Exploring roles of protein deamidation in oral inflammation
-
批准号:9752511
-
项目类别:
-
资助金额:$104.23万
-
财政年份:2017
-
负责人:Pinghui Feng
-
依托单位:
Exploring roles of protein deamidation in oral inflammation
-
批准号:9461929
-
项目类别:
-
资助金额:$67.72万
-
财政年份:2017
-
负责人:Pinghui Feng
-
依托单位:
NFAT activation in kGPCR tumorigenesis
-
批准号:9410699
-
项目类别:
-
资助金额:$37.74万
-
财政年份:2017
-
负责人:Pinghui Feng
-
依托单位:
NFAT activation in kGPCR tumorigenesis
-
批准号:10251852
-
项目类别:
-
资助金额:$37.74万
-
财政年份:2017
-
负责人:Pinghui Feng
-
依托单位:
Targeting an immune kinase to purge KSHV latent infection
-
批准号:9116597
-
项目类别:
-
资助金额:$67.66万
-
财政年份:2016
-
负责人:Pinghui Feng
-
依托单位:
Targeting an immune kinase to purge KSHV latent infection
-
批准号:9242614
-
项目类别:
-
资助金额:$67.66万
-
财政年份:2016
-
负责人:Pinghui Feng
-
依托单位:
A recombinant virus approach for gamma herpesvirus oncogenesis
-
批准号:8638543
-
项目类别:
-
资助金额:$24.63万
-
财政年份:2013
-
负责人:Pinghui Feng
-
依托单位:
Proviral Roles of an Innate Immune Pathway
-
批准号:8184241
-
项目类别:
-
资助金额:$40.75万
-
财政年份:2011
-
负责人:Pinghui Feng
-
依托单位:
Protein Deamidation in Innate Immune Evasion Regulated by Viral Pseudo Enzymes
-
批准号:9381580
-
项目类别:
-
资助金额:$45.48万
-
财政年份:2011
-
负责人:Pinghui Feng
-
依托单位:
Proviral Roles of an Innate Immune Pathway
-
批准号:8846572
-
项目类别:
-
资助金额:$41.25万
-
财政年份:2011
-
负责人:Pinghui Feng
-
依托单位:
Proviral Roles of an Innate Immune Pathway
-
批准号:8469753
-
项目类别:
-
资助金额:$39.36万
-
财政年份:2011
-
负责人:Pinghui Feng
-
依托单位:
Proviral Roles of an Innate Immune Pathway
-
批准号:8326568
-
项目类别:
-
资助金额:$41.0万
-
财政年份:2011
-
负责人:Pinghui Feng
-
依托单位:
Post-Translational Events Underlying the KSHV vGPCR Pathogenesis
-
批准号:8060647
-
项目类别:
-
资助金额:$10.04万
-
财政年份:2009
-
负责人:Pinghui Feng
-
依托单位:
Post-Translational Events Underlying the KSHV vGPCR Pathogenesis
-
批准号:8460123
-
项目类别:
-
资助金额:$31.03万
-
财政年份:2009
-
负责人:Pinghui Feng
-
依托单位:
Post-Translational Events Underlying the KSHV vGPCR Pathogenesis
-
批准号:7755457
-
项目类别:
-
资助金额:$31.39万
-
财政年份:2009
-
负责人:Pinghui Feng
-
依托单位:
Post-Translational Events Underlying the KSHV vGPCR Pathogenesis
-
批准号:8367335
-
项目类别:
-
资助金额:$22.4万
-
财政年份:2009
-
负责人:Pinghui Feng
-
依托单位:
INHIBITION OF MITOCHONDRION-DEPENDENT APOPTOSIS BY HERPESVIRAL PROTEIN
-
批准号:7715509
-
项目类别:
-
资助金额:$3.24万
-
财政年份:2008
-
负责人:Pinghui Feng
-
依托单位:
GAMMAHV68 VMAP MITOCHONDRIAL ANTI-APOPTOSIS PROTEIN
-
批准号:7562107
-
项目类别:
-
资助金额:$3.16万
-
财政年份:2007
-
负责人:Pinghui Feng
-
依托单位:
海外基金